docetaxel anhydrous has been researched along with Pleural Effusion, Malignant in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, K; Dotsu, Y; Fukuda, M; Gyotoku, H; Ikeda, T; Kinoshita, A; Kitazaki, T; Mukae, H; Nagashima, S; Nakatomi, K; Senju, H; Soda, H; Takemoto, S; Taniguchi, H; Tomono, H; Umeyama, Y; Yamaguchi, H | 1 |
| Ando, M; Gemma, A; Hagiwara, K; Hino, M; Kobayashi, K; Kubota, K; Miyanaga, A; Nishitsuji, M; Noro, R; Seike, M; Shimokawa, T; Usuki, J; Yomota, M | 1 |
| Acheson, A; Aung, S; Coffey, T; Fisher, B; Fox, BA; Hilton, T; Hu, HM; Moudgil, T; Neuberger, M; Paustian, C; Puri, S; Ross, HJ; Sanborn, RE; Urba, WJ; Walker, E | 1 |
| Akiba, J; Azuma, K; Hoshino, T; Ishii, H; Masuda, K; Matsuo, N; Naito, Y; Sakazaki, Y; Tokito, T; Tsuneyoshi, S; Yamada, K; Zaizen, Y | 1 |
| Conroy, M; Greally, M; MacEneaney, O; McCaffrey, J; O’Keane, C | 1 |
| Choi, CM; Choi, MG; Ji, W; Kim, HR; Lee, GD; Lee, JC; Oh, DK; Park, S | 1 |
| Leighl, NB; Zer, A | 1 |
| Hasegawa, S; Kimura, S; Maekawa, T; Matsumoto, S; Sato, K; Tanaka, F; Wada, H | 1 |
| Burks, SG; Daniel, TM; Gillenwater, HH; Jones, DR; Petroni, GR; Shu, J; Taylor, MD | 1 |
| Chen, X; Ding, Y; Liu, B; Qian, X; Wang, L; Wang, T; Wei, J; Xie, L; Yu, L; Zhang, C | 1 |
| Itou, S; Kanazawa, J; Namba, R; Nawa, T; Yamamoto, Y | 1 |
| Coudillo-Luna, I; Novoa-Vargas, A; Sánchez-Bautista, K | 1 |
| Hihara, J; Minami, K; Ohta, K; Tanabe, K; Toge, T; Yamaguchi, Y; Yoshida, K | 1 |
| Akiba, Y; Hibi, T; Hosoe, N; Ishii, H; Izumiya, M; Mori, S; Nagata, H; Suzuki, J; Takaishi, H; Ueda, T; Yamagishi, Y | 1 |
| Aiba, K; Hagino, T; Hirano, A; Kawase, K; Kobayashi, M; Kobayashi, T; Okawa, Y; Shioya, H; Sugiyama, K; Uno, S; Usui, N; Yoshida, K | 1 |
| Suzuki, M | 1 |
| Funahashi, H; Hayashi, H; Imai, T; Itoh, T; Kikumori, T; Mase, T; Oiwa, M; Sekiya, M; Shibata, A | 1 |
| Hazama, K; Kagisaki, K; Matsuda, H; Miyoshi, S; Ohta, M; Shintani, Y | 1 |
3 review(s) available for docetaxel anhydrous and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA-Binding Proteins; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Profiling; Genotype; Glutamates; Guanine; Humans; Keratin-7; Lung Neoplasms; Middle Aged; Palliative Care; Pemetrexed; Pleural Effusion, Malignant; Quinazolines; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Taxoids; Transcription Factors; Treatment Failure | 2014 |
[Malignant arrhenoblastoma. Case report and literature review].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carboplatin; Combined Modality Therapy; Diagnostic Imaging; Docetaxel; Female; Humans; Hysterectomy; Ovarian Neoplasms; Ovariectomy; Pleural Effusion, Malignant; Sertoli-Leydig Cell Tumor; Taxoids; Virilism | 2011 |
Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Pericardial Effusion; Pleural Effusion, Malignant; Taxoids; Thymus Neoplasms; Vena Cava, Superior | 2001 |
4 trial(s) available for docetaxel anhydrous and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Docetaxel; Follow-Up Studies; Humans; Lung Neoplasms; Multicenter Studies as Topic; Pleural Effusion, Malignant; Prognosis; Ramucirumab; Salvage Therapy; Survival Rate | 2020 |
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pemetrexed; Pleural Effusion, Malignant; Pleurodesis; Prognosis; Survival Rate | 2020 |
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Autophagosomes; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Injections, Intradermal; Interferon-gamma; Interleukin-10; Interleukin-5; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pleural Effusion, Malignant; Taxoids; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion.
Topics: Adult; Aged; Antineoplastic Agents; Catheters, Indwelling; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pleural Effusion, Malignant; Prognosis; Survival Rate; Taxoids; Tissue Distribution; Treatment Outcome | 2010 |
11 other study(ies) available for docetaxel anhydrous and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma, Squamous Cell; Docetaxel; Etoposide; Humans; Immunohistochemistry; Lung Neoplasms; Male; Pleural Effusion, Malignant; Small Cell Lung Carcinoma | 2018 |
Sarcomatoid Carcinoma of the Prostate Presenting in a 44 Year Old
Topics: Adult; Biopsy; Carcinosarcoma; Combined Modality Therapy; Docetaxel; Heart Neoplasms; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Palliative Care; Pleural Effusion, Malignant; Prostatic Neoplasms; Radiotherapy; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2018 |
Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pleural Effusion, Malignant; Prognosis; Prospective Studies; Quality of Life; Surgery, Computer-Assisted; Thoracoscopy; Treatment Outcome | 2019 |
Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Monitoring; Female; Humans; Injections; Luciferases, Firefly; Lung Neoplasms; Mice; Mice, Inbred BALB C; Pleural Effusion, Malignant; Taxoids; Treatment Outcome | 2009 |
Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell-Free System; Docetaxel; Female; Gene Expression Profiling; Humans; Lung Neoplasms; Male; MicroRNAs; Middle Aged; Pleural Effusion, Malignant; Reverse Transcriptase Polymerase Chain Reaction; Taxoids | 2010 |
[A case of angiosarcoma of the scalp with severe fluid retention after administering docetaxel].
Topics: Aged; Antineoplastic Agents; Biopsy; Combined Modality Therapy; Docetaxel; Drainage; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Pleural Effusion, Malignant; Scalp; Skin Neoplasms; Taxoids; Tomography, X-Ray Computed | 2011 |
[Weekly docetaxel therapy is useful for gastric carcinoma as a second-line chemotherapy].
Topics: Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Stomach Neoplasms; Taxoids | 2003 |
[A case of recurrent pleural effusion and positive cytology of advanced gastric cancer treated by TS-1 plus weekly taxane as second-line chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-19-9 Antigen; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Oxonic Acid; Pleural Effusion, Malignant; Pyridines; Stomach Neoplasms; Taxoids; Tegafur | 2004 |
Successful combination therapy with trastuzumab and Paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Docetaxel; Doxorubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Paclitaxel; Pleural Effusion, Malignant; Taxoids; Trastuzumab; Treatment Outcome | 2004 |
[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Pleural Effusion, Malignant; Pleural Neoplasms; Quality of Life; Remission Induction; Taxoids; Toremifene | 2007 |
[Administration of docetaxel in cases of recurrent breast carcinoma with malignant pleural effusion controlled by intrapleural administration of OK-432].
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Pleura; Pleural Effusion, Malignant; Taxoids | 1999 |